Cargando…

Synthesis of Asparagine Derivatives Harboring a Lewis X Type DC‐SIGN Ligand and Evaluation of their Impact on Immunomodulation in Multiple Sclerosis

The protein myelin oligodendrocyte glycoprotein (MOG) is a key component of myelin and an autoantigen in the disease multiple sclerosis (MS). Post‐translational N‐glycosylation of Asn(31) of MOG seems to play a key role in modulating the immune response towards myelin. This is mediated by the intera...

Descripción completa

Detalles Bibliográficos
Autores principales: Doelman, Ward, Marqvorsen, Mikkel H. S., Chiodo, Fabrizio, Bruijns, Sven C. M., van der Marel, Gijsbert A., van Kooyk, Yvette, van Kasteren, Sander I., Araman, Can
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898482/
https://www.ncbi.nlm.nih.gov/pubmed/33090600
http://dx.doi.org/10.1002/chem.202004076
_version_ 1783653868519817216
author Doelman, Ward
Marqvorsen, Mikkel H. S.
Chiodo, Fabrizio
Bruijns, Sven C. M.
van der Marel, Gijsbert A.
van Kooyk, Yvette
van Kasteren, Sander I.
Araman, Can
author_facet Doelman, Ward
Marqvorsen, Mikkel H. S.
Chiodo, Fabrizio
Bruijns, Sven C. M.
van der Marel, Gijsbert A.
van Kooyk, Yvette
van Kasteren, Sander I.
Araman, Can
author_sort Doelman, Ward
collection PubMed
description The protein myelin oligodendrocyte glycoprotein (MOG) is a key component of myelin and an autoantigen in the disease multiple sclerosis (MS). Post‐translational N‐glycosylation of Asn(31) of MOG seems to play a key role in modulating the immune response towards myelin. This is mediated by the interaction of Lewis‐type glycan structures in the N‐glycan of MOG with the DC‐SIGN receptor on dendritic cells (DCs). Here, we report the synthesis of an unnatural Lewis X (Le(X))‐containing Fmoc‐SPPS‐compatible asparagine building block (SPPS=solid‐phase peptide synthesis), as well as asparagine building blocks containing two Le(X)‐derived oligosaccharides: LacNAc and Fucα1‐3GlcNAc. These building blocks were used for the glycosylation of the immunodominant portion of MOG (MOG(31‐55)) and analyzed with respect to their ability to bind to DC‐SIGN in different biological setups, as well as their ability to inhibit the citrullination‐induced aggregation of MOG(31‐55). Finally, a cytokine secretion assay was carried out on human monocyte‐derived DCs, which showed the ability of the neoglycopeptide decorated with a single Le(X) to alter the balance of pro‐ and anti‐inflammatory cytokines, inducing a tolerogenic response.
format Online
Article
Text
id pubmed-7898482
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-78984822021-03-03 Synthesis of Asparagine Derivatives Harboring a Lewis X Type DC‐SIGN Ligand and Evaluation of their Impact on Immunomodulation in Multiple Sclerosis Doelman, Ward Marqvorsen, Mikkel H. S. Chiodo, Fabrizio Bruijns, Sven C. M. van der Marel, Gijsbert A. van Kooyk, Yvette van Kasteren, Sander I. Araman, Can Chemistry Full Papers The protein myelin oligodendrocyte glycoprotein (MOG) is a key component of myelin and an autoantigen in the disease multiple sclerosis (MS). Post‐translational N‐glycosylation of Asn(31) of MOG seems to play a key role in modulating the immune response towards myelin. This is mediated by the interaction of Lewis‐type glycan structures in the N‐glycan of MOG with the DC‐SIGN receptor on dendritic cells (DCs). Here, we report the synthesis of an unnatural Lewis X (Le(X))‐containing Fmoc‐SPPS‐compatible asparagine building block (SPPS=solid‐phase peptide synthesis), as well as asparagine building blocks containing two Le(X)‐derived oligosaccharides: LacNAc and Fucα1‐3GlcNAc. These building blocks were used for the glycosylation of the immunodominant portion of MOG (MOG(31‐55)) and analyzed with respect to their ability to bind to DC‐SIGN in different biological setups, as well as their ability to inhibit the citrullination‐induced aggregation of MOG(31‐55). Finally, a cytokine secretion assay was carried out on human monocyte‐derived DCs, which showed the ability of the neoglycopeptide decorated with a single Le(X) to alter the balance of pro‐ and anti‐inflammatory cytokines, inducing a tolerogenic response. John Wiley and Sons Inc. 2020-12-28 2021-02-05 /pmc/articles/PMC7898482/ /pubmed/33090600 http://dx.doi.org/10.1002/chem.202004076 Text en © 2020 The Authors. Chemistry - A European Journal published by Wiley-VCH GmbH This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Full Papers
Doelman, Ward
Marqvorsen, Mikkel H. S.
Chiodo, Fabrizio
Bruijns, Sven C. M.
van der Marel, Gijsbert A.
van Kooyk, Yvette
van Kasteren, Sander I.
Araman, Can
Synthesis of Asparagine Derivatives Harboring a Lewis X Type DC‐SIGN Ligand and Evaluation of their Impact on Immunomodulation in Multiple Sclerosis
title Synthesis of Asparagine Derivatives Harboring a Lewis X Type DC‐SIGN Ligand and Evaluation of their Impact on Immunomodulation in Multiple Sclerosis
title_full Synthesis of Asparagine Derivatives Harboring a Lewis X Type DC‐SIGN Ligand and Evaluation of their Impact on Immunomodulation in Multiple Sclerosis
title_fullStr Synthesis of Asparagine Derivatives Harboring a Lewis X Type DC‐SIGN Ligand and Evaluation of their Impact on Immunomodulation in Multiple Sclerosis
title_full_unstemmed Synthesis of Asparagine Derivatives Harboring a Lewis X Type DC‐SIGN Ligand and Evaluation of their Impact on Immunomodulation in Multiple Sclerosis
title_short Synthesis of Asparagine Derivatives Harboring a Lewis X Type DC‐SIGN Ligand and Evaluation of their Impact on Immunomodulation in Multiple Sclerosis
title_sort synthesis of asparagine derivatives harboring a lewis x type dc‐sign ligand and evaluation of their impact on immunomodulation in multiple sclerosis
topic Full Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898482/
https://www.ncbi.nlm.nih.gov/pubmed/33090600
http://dx.doi.org/10.1002/chem.202004076
work_keys_str_mv AT doelmanward synthesisofasparaginederivativesharboringalewisxtypedcsignligandandevaluationoftheirimpactonimmunomodulationinmultiplesclerosis
AT marqvorsenmikkelhs synthesisofasparaginederivativesharboringalewisxtypedcsignligandandevaluationoftheirimpactonimmunomodulationinmultiplesclerosis
AT chiodofabrizio synthesisofasparaginederivativesharboringalewisxtypedcsignligandandevaluationoftheirimpactonimmunomodulationinmultiplesclerosis
AT bruijnssvencm synthesisofasparaginederivativesharboringalewisxtypedcsignligandandevaluationoftheirimpactonimmunomodulationinmultiplesclerosis
AT vandermarelgijsberta synthesisofasparaginederivativesharboringalewisxtypedcsignligandandevaluationoftheirimpactonimmunomodulationinmultiplesclerosis
AT vankooykyvette synthesisofasparaginederivativesharboringalewisxtypedcsignligandandevaluationoftheirimpactonimmunomodulationinmultiplesclerosis
AT vankasterensanderi synthesisofasparaginederivativesharboringalewisxtypedcsignligandandevaluationoftheirimpactonimmunomodulationinmultiplesclerosis
AT aramancan synthesisofasparaginederivativesharboringalewisxtypedcsignligandandevaluationoftheirimpactonimmunomodulationinmultiplesclerosis